* Dolby Laboratories Inc DLB.N DLB is expected to show a
rise
in quarterly revenue when it reports results on November 17.
* The San Francisco California-based company is expected to
report a 7.1% increase in revenue to $305.226 million from
$285.03 million a year ago, according to the mean estimate from
4 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Dolby Laboratories
Inc is
for earnings of 71 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Dolby
Laboratories Inc is $87.5, above its last closing price
of $70.59.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.59 0.59 0.68 Beat 16.2
Mar. 31 2022 0.82 0.82 0.92 Beat 12.7
Dec. 31 2021 1.06 1.06 1.01 Missed -4.9
Sep. 30 2021 0.56 0.56 0.58 Beat 3.1
Jun. 0.48 0.48 0.71 Beat 49.5
30 2021
Mar. 31 2021 0.67 0.67 0.91 Beat 36.5
Dec. 31 2020 1.04 1.04 1.48 Beat 41.8
Sep. 30 2020 0.34 0.34 0.45 Beat 33.1
This summary was machine generated November 15 at 21:34 GMT.
All figures in US dollars unless otherwise stated